{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:17:11Z","timestamp":1791274631549,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ahj.2019.10.003","type":"journal-article","created":{"date-parts":[[2019,10,20]],"date-time":"2019-10-20T17:06:58Z","timestamp":1571591218000},"page":"246-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":114,"special_numbering":"C","title":["Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)"],"prefix":"10.1016","volume":"220","author":[{"given":"David","family":"Birnie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S.B.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn D.","family":"Aaron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"DeKemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorne","family":"Gula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery S.","family":"Healey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Judson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Juneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Varnava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Wickremasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordana","family":"Kron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ahj.2019.10.003_bb0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur Respir J."},{"issue":"1","key":"10.1016\/j.ahj.2019.10.003_bb0010","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis."},{"issue":"9923","key":"10.1016\/j.ahj.2019.10.003_bb0015","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"385","author":"Valeyre","year":"2013","journal-title":"Lancet."},{"key":"10.1016\/j.ahj.2019.10.003_bb0020","doi-asserted-by":"crossref","unstructured":"Al-Kindi SG, Oliveira GH. Letter by Al-Kindi and Oliveira regarding article \u201ccardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study\u201d. Circulation. 2015;132(17):e211.","DOI":"10.1161\/CIRCULATIONAHA.115.016258"},{"issue":"7","key":"10.1016\/j.ahj.2019.10.003_bb0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25\u202fyears in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation."},{"issue":"3","key":"10.1016\/j.ahj.2019.10.003_bb0030","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac Sarcoidosis and Giant Cell Myocarditis as Causes of Atrioventricular Block in Young and Middle-Aged Adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol."},{"issue":"8","key":"10.1016\/j.ahj.2019.10.003_bb0035","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol."},{"key":"10.1016\/j.ahj.2019.10.003_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/pace.12277","article-title":"Prevalence of Cardiac Sarcoidosis in Patients Presenting with Monomorphic Ventricular Tachycardia","volume":"37","author":"Nery","year":"2013","journal-title":"Pacing Clin Electrophysiol."},{"issue":"12","key":"10.1016\/j.ahj.2019.10.003_bb0045","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm."},{"issue":"17","key":"10.1016\/j.ahj.2019.10.003_bb0050","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJM199704243361706","article-title":"Sarcoidosis","volume":"336","author":"Newman","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ahj.2019.10.003_bb0055","article-title":"Corticosteroids for pulmonary sarcoidosis","volume":"2","author":"Paramothayan","year":"2005","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.ahj.2019.10.003_bb0060","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1183\/09031936.06.00105805","article-title":"Corticosteroid treatment in sarcoidosis","volume":"28","author":"Grutters","year":"2006","journal-title":"Eur Respir J."},{"issue":"3 Pt 1","key":"10.1016\/j.ahj.2019.10.003_bb0065","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1164\/ajrccm\/151.3_Pt_1.920a","article-title":"Outcome of the treatment for sarcoidosis","volume":"151","author":"Israel","year":"1995","journal-title":"Am J Respir Crit Care Med."},{"issue":"Suppl 5","key":"10.1016\/j.ahj.2019.10.003_bb0070","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63","author":"Bradley","year":"2008","journal-title":"Thorax."},{"issue":"9","key":"10.1016\/j.ahj.2019.10.003_bb0075","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol."},{"issue":"1","key":"10.1016\/j.ahj.2019.10.003_bb0080","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s12350-013-9828-6","article-title":"Reduction in F-fluorodeoxyglucose uptake on serial cardiac positron emission tomography is associated with improved left ventricular ejection fraction in patients with cardiac sarcoidosis","volume":"21","author":"Osborne","year":"2014","journal-title":"J Nucl Cardiol."},{"issue":"4","key":"10.1016\/j.ahj.2019.10.003_bb0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med."},{"issue":"5","key":"10.1016\/j.ahj.2019.10.003_bb0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr Opin Pulm Med."},{"issue":"23","key":"10.1016\/j.ahj.2019.10.003_bb0095","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.2169\/internalmedicine.53.3120","article-title":"Treatment with Methotrexate and Low-dose Corticosteroids in Sarcoidosis Patients with Cardiac Lesions","volume":"53","author":"Nagai","year":"2014","journal-title":"Intern Med."},{"issue":"9","key":"10.1016\/j.ahj.2019.10.003_bb0100","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/S0002-9149(01)01978-6","article-title":"Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone","volume":"88","author":"Yazaki","year":"2001","journal-title":"Am J Cardiol."},{"issue":"7","key":"10.1016\/j.ahj.2019.10.003_bb0105","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cardfail.2006.05.012","article-title":"Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure","volume":"12","author":"Yan","year":"2006","journal-title":"J Card Fail."},{"issue":"1","key":"10.1016\/j.ahj.2019.10.003_bb0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","article-title":"The development and validation of the King's Sarcoidosis Questionnaire for the assessment of health status","volume":"68","author":"Patel","year":"2013","journal-title":"Thorax."},{"issue":"7","key":"10.1016\/j.ahj.2019.10.003_bb0115","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1164\/rccm.201410-1785OC","article-title":"Validation and Important Differences for The Sarcoidosis Assessment Tool: A New Patient Reported Outcome Measure","volume":"191","author":"Judson","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"issue":"2 Pt 2","key":"10.1016\/j.ahj.2019.10.003_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on (18)F-FDG PET Scans for Suspected Cardiac Sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"issue":"3","key":"10.1016\/j.ahj.2019.10.003_bb0125","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","article-title":"Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis","volume":"21","author":"Ziegenhagen","year":"2003","journal-title":"Eur Respir J."},{"issue":"2","key":"10.1016\/j.ahj.2019.10.003_bb0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir Med."},{"issue":"7","key":"10.1016\/j.ahj.2019.10.003_bb0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00259-009-1097-x","article-title":"18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis","volume":"36","author":"Keijsers","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"5","key":"10.1016\/j.ahj.2019.10.003_bb0140","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1536\/ihj.17-695","article-title":"A Multiple Biomarker Approach in Patients with Cardiac Sarcoidosis","volume":"59","author":"Kiko","year":"2018","journal-title":"Int Heart J."},{"issue":"6","key":"10.1016\/j.ahj.2019.10.003_bb0145","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.amjcard.2015.06.021","article-title":"Usefulness of Cardiac Troponins as Markers of Early Treatment Response in Cardiac Sarcoidosis","volume":"116","author":"Kandolin","year":"2015","journal-title":"Am J Cardiol."}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870319302789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:04:45Z","timestamp":1757570685000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870319302789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"alternative-id":["S0002870319302789"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.003","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2019.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}